Literature DB >> 25685367

Combined Positron Emission Tomography and Computed Tomography: Option or necessity?

Naima K Al-Bulushi1.   

Abstract

Year:  2015        PMID： 25685367      PMCID： PMC4318588          DOI： 10.18295/squmj.2015.15.01.001

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN： 2075-051X


× No keyword cloud information.
  15 in total

Review 1.  Established, emerging and future roles of PET/CT in the management of colorectal cancer.

Authors:  R A Herbertson; A F Scarsbrook; S T Lee; N Tebbutt; A M Scott
Journal:  Clin Radiol       Date:  2008-10-23       Impact factor: 2.350

2.  The Medical Case for a Positron Emission Tomography and X-ray Computed Tomography Combined Service in Oman.

Authors:  Naima K Al-Bulushi; Dale Bailey; Giuliano Mariani
Journal:  Sultan Qaboos Univ Med J       Date:  2013-11-08

3.  Incidental diagnosis of thrombus within an aneurysm on 18F-FDG PET/CT: frequency in 926 patients.

Authors:  Razi Muzaffar; Ganesh Kudva; Nghi C Nguyen; Medhat M Osman
Journal:  J Nucl Med       Date:  2011-08-04       Impact factor: 10.057

4.  What does a National Health Service mean in the 21st century?

Authors:  Richard Horton
Journal:  Lancet       Date:  2008-06-28       Impact factor: 79.321

5.  Selective Use of (18)F-Fluorodeoxyglucose-Positron Emission Tomography and Computed Tomography in the Management of Metastatic Disease from Colorectal Cancer: Results from a regional centre.

Authors:  Sadaf Jafferbhoy; Adam Chambers; James Mander; Hugh Paterson
Journal:  Sultan Qaboos Univ Med J       Date:  2015-01-21

6.  Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.

Authors:  Freddie Bray; Ahmedin Jemal; Nathan Grey; Jacques Ferlay; David Forman
Journal:  Lancet Oncol       Date:  2012-06-01       Impact factor: 41.316

7.  Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center.

Authors:  Pek-Lan Khong; Bingsheng Huang; Elaine Yuen Phin Lee; Winnie Kit Sum Chan; Yok-Lam Kwong
Journal:  J Nucl Med       Date:  2014-05-12       Impact factor: 10.057

8.  Non-Hodgkin lymphoma: retrospective study on the cost-effectiveness of early treatment response assessment by FDG-PET.

Authors:  G Moulin-Romsee; K Spaepen; S Stroobants; L Mortelmans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-25       Impact factor: 9.236

9.  Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.

Authors:  Amparo L Figueroa; Amr Abdelbaky; Quynh A Truong; Erin Corsini; Megan H MacNabb; Zachary R Lavender; Meredith A Lawler; Steven K Grinspoon; Thomas J Brady; Khurram Nasir; Udo Hoffmann; Ahmed Tawakol
Journal:  JACC Cardiovasc Imaging       Date:  2013-10-23

10.  Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.

Authors:  Kristin Skougaard; Dorte Nielsen; Benny Vittrup Jensen; Helle Westergren Hendel
Journal:  J Nucl Med       Date:  2013-04-09       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.